Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy

This publication has 9 references indexed in Scilit:

• Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies
  Parkinsonism & Related Disorders, 2016
• Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells
  The Journal of Pharmacology and Experimental Therapeutics, 2016
• Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy
  Parkinsonism & Related Disorders, 2015
• Is Parkinson's Disease a Vesicular Dopamine Storage Disorder? Evidence from a Study in Isolated Synaptic Vesicles of Human and Nonhuman Primate Striatum
  The Journal of Neuroscience, 2014
• Determinants of buildup of the toxic dopamine metaboliteDOPALin Parkinson's disease
  Journal of Neurochemistry, 2013
• Incidental Lewy Body Disease and Preclinical Parkinson Disease
  Archives of Neurology, 2008
• Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat
  Journal of Neural Transmission, 2001
• Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
  Annals of Neurology, 1990
• Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
  New England Journal of Medicine, 1988